CDK5 and Alzheimer disease: For example, dysregulation of cyclin-dependent kinase 5 (CDK5) triggers the formation of Aβ plaques and NFTs, synaptic damage, mitochondrial dysfunction, and neuronal apoptosis, which are among a series of AD-related pathological events [20].